Vijaya Diagnostic Centre share price
NSE: VIJAYABSE: 543350Healthcare ServicesSmall Cap
Share price at the NSE close on 28 Oct 2026. Previous close ₹1,442.70.
28 Oct: open ₹1,442.70, high ₹1,458.00, low ₹1,422.30
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹14,861 Cr523rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 79.26
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 15.53
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.14%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 21.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 27.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 37,97344.8% delivered
About Vijaya Diagnostic Centre
Vijaya Diagnostic Centre Limited runs diagnostic centres and laboratories that offer pathology and radiology tests. It serves individuals, clinicians and institutions. It also provides corporate wellness programmes that combine health check-ups with specialised diagnostic packages for employers. It was incorporated in 2002 and is headquartered in Hyderabad.
The company brings pathology and radiology together on a single platform, so a patient can have both kinds of tests at one centre. Its imaging equipment includes 3T MRI, advanced CT scanners, digital PET-CT and gamma cameras. Central and reference laboratories work together with a hub-and-spoke network of centres, in which large laboratories process samples collected at smaller centres. Patients can book appointments online and use home sample collection. Its laboratories hold NABL accreditation, a national quality standard for testing laboratories.
The company operates centres in Andhra Pradesh, Telangana, West Bengal, Maharashtra, Karnataka and Gurgaon. It opened its first centre under the Vijaya brand in Kolkata. In Bengaluru, it launched hub centres at Yelahanka and HSR Layout under the Vijaya brand. It entered the Pune market by acquiring a 100% stake in P.H. Diagnostics. Its shares are listed on the NSE and BSE.
The company is led by its promoter, Dr Sura Surendranath Reddy, who is its executive chairman. A promoter is the person or group that set up a company or controls it.
Written from the annual report for the year to Mar 2026, filed 26 Aug 2026 and the investor presentation.
Sources for 21 statements, each with its page
- The company offers pathology and radiology diagnostic tests. Annual report, page 4
- It serves individuals, clinicians and institutions, and brings pathology and radiology together on a single platform. Annual report, page 4
- It provides corporate wellness solutions combining pathology and radiology for organisations. Annual report, page 4
- It was incorporated in 2002. Annual report, page 30
- It is headquartered in Hyderabad. Annual report, page 4
- Imaging equipment includes 3T MRI and advanced CT scanners. Annual report, page 8
- Imaging equipment includes digital PET-CT and gamma camera. Annual report, page 8
- Central and reference laboratories work with the hub-and-spoke network. Annual report, page 8
- It uses a hub-and-spoke operating model. Annual report, page 4
- Patients can book appointments online. Annual report, page 9
- It offers home collection services. Annual report, page 9
- Its laboratories are NABL accredited. Annual report, page 4
- It operates in Andhra Pradesh and Telangana. Annual report, page 4
- It operates in West Bengal and Maharashtra. Annual report, page 4
- It operates in Karnataka and Gurgaon. Annual report, page 4
- It launched its first centre under the Vijaya brand in Kolkata. Annual report, page 10
- It launched hub centres in Bengaluru at Yelahanka and HSR Layout under the Vijaya brand. Annual report, page 10
- It acquired a 100% stake in P.H. Diagnostics, entering the Pune market. Annual report, page 10
- Acquisition marked its entry into Pune. Annual report, page 10
- Its shares are listed on NSE and BSE. Annual report, page 10
- Dr Sura Surendranath Reddy is the promoter and executive chairman. Annual report, page 72
Results
Consolidated; ₹ crore.Vijaya Diagnostic Centre quarterly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +20.2%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +24.9%
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹231 Crup 5.29%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹53 Crup 10.79%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 23.0%
Revenue by quarter
Net profit by quarter, a loss in red
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 183 | 169 | 173 | 188 | 202 | 205 | 219 | 231 |
| Net profit | 42 | 35 | 35 | 39 | 43 | 43 | 48 | 53 |
| Net margin | 23.0% | 20.9% | 20.1% | 20.5% | 21.5% | 21.0% | 21.8% | 23.0% |
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹814 Crup 19.49%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹173 Crup 20.30%
- Net margin
- 21.2%
Revenue by year
Net profit by year, a loss in red
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 462 | 459 | 548 | 681 | 814 |
| Net profit | 111 | 85 | 120 | 144 | 173 |
| Net margin | 23.9% | 18.6% | 21.8% | 21.1% | 21.2% |
Business segments
In the year to Mar 2026 the company reports one business segment, Diagnostic Services, which carries all its revenue.
Valuation
Today, against the company's own history.Vijaya Diagnostic Centre PE ratio and valuation
At or below today's level on 87% of 1,089 trading days since Jun 2022.
At or below today's level on 94% of 1,232 trading days since Nov 2021.
At or below today's level on 47% of 1,228 trading days over the last 5 years.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −14.2% | +20.5% | −29.0% | 0.2% |
| 3 years | +30.3% | +26.6% | +2.8% | 0.2% |
Mutual fund holdings
107 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 48 of the 59 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future.All 107 funds holding Vijaya Diagnostic Centre
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 2
- Bought againBought again. Funds that held it at the month's end, had not held it the month before, and held it in an earlier month.
- 1
- AddedAdded. Funds that held more shares than at the end of the month before.
- 21
- CutCut. Funds that held fewer shares than at the end of the month before.
- 38
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 45
| Fund | |||
|---|---|---|---|
 Kotak-Small Cap FundKotak Mahindra Mutual Fund | 54,54,656 | 4.10% | ₹784.2 Cr |
 HDFC Small Cap FundHDFC Mutual Fund | 46,16,178 | 1.63% | ₹663.7 Cr |
 Nippon India Multi Cap FundNippon India Mutual Fund | 29,13,646 | 0.78% | ₹418.9 Cr |
 HSBC Small Cap FundHSBC Mutual Fund | 25,03,558 | 1.94% | ₹359.9 Cr |
 Axis Small Cap FundAxis Mutual Fund | 20,61,599 | 0.97% | ₹296.4 Cr |
| Nippon India Pharma FundNippon India Mutual Fund | 16,71,618 | 2.62% | ₹240.3 Cr |
 ICICI Prudential Flexi Cap FundICICI Prudential Mutual Fund | 12,89,654 | 0.74% | ₹185.4 Cr |
 Motilal Oswal Small Cap FundMotilal Oswal Mutual Fund | 12,37,085 | 2.14% | ₹177.9 Cr |
| ICICI Prudential Innovation FundICICI Prudential Mutual Fund | 9,87,292 | 1.88% | ₹141.9 Cr |
| Kotak Business Cycle FundKotak Mahindra Mutual Fund | 7,37,748 | 3.11% | ₹106.1 Cr |
Promoter and insider buying and selling
Trades made since 28 Oct 2025.Vijaya Diagnostic Centre insider trading
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade · 2 pledge filings of unclear kind
- Others: no market trade · 3 pledge filings of unclear kind
Vijaya Diagnostic Centre competitors and peers
Healthcare Service Provider, 37 listed companies, priced on 28 Oct 2026. The table lists the 8 companies closest to Vijaya Diagnostic Centre in market cap.Healthcare companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Dr. Lal Path LabsLALPATHLAB | 32,266 | 59.54 | 12.86 | +14.3% | +5.6% | 23.2% | 26.2% | 0.83% |
 Metropolis HealthcareMETROPOLIS | 11,435 | 56.71 | 7.56 | +21.8% | +32.6% | 14.2% | 18.6% | 0.36% |
 Thyrocare TechnologiesTHYROCARE | 7,871 | 44.64 | 13.44 | +21.1% | +65.7% | 31.1% | 37.9% | 1.42% |
 Nephrocare Health ServicesNEPHROPLUS | 6,319 | – | 5.66 | – | – | – | – | 0.00% |
 Suraksha DiagnosticSURAKSHA | 1,623 | 45.35 | 6.63 | +23.3% | +8.1% | 15.7% | 24.0% | 0.16% |
 Krsnaa DiagnosticsKRSNAA | 1,610 | 16.52 | 1.64 | +10.2% | +21.5% | 10.5% | 8.0% | 0.40% |
 3B Blackbio Dx3BBLACKBIO | 1,170 | 21.07 | 3.61 | +54.3% | +13.2% | 18.7% | 14.1% | 0.37% |
 One Global Service ProviderONEGLOBAL | 918 | 12.41 | 6.50 | +161.6% | +178.3% | 69.4% | 69.2% | 0.21% |
Dividends
Per share, by the year it was paid for, and the latest payments.Vijaya Diagnostic Centre dividend history
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up. Dividend per share in the glossary| Ex-date | Type | Per share |
|---|---|---|
| 16 Sep 2026 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. Final dividend in the glossary | ₹2.00 |
| 29 Aug 2025 | Final | ₹2.00 |
| 30 Aug 2024 | Final | ₹1.00 |
| 13 Sep 2023 | Final | ₹1.00 |
| 20 Sep 2022 | Final | ₹1.00 |
Latest announcements
Routine notices left out.Vijaya Diagnostic Centre announcements
Oct 2026
28 Oct · Analysts
Sep 2026
24 Sep · Meeting
Vijaya Diagnostic Centre share price by year
Each calendar year to 2025.Vijaya Diagnostic Centre share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 1,061.00 | +0.4% | 1,241.80 | 891.20 |
| 2024 | 1,056.85 | +56.4% | 1,219.65 | 604.35 |
| 2023 | 675.70 | +54.6% | 675.70 | 352.25 |
| 2022 | 437.15 | −25.0% | 598.75 | 300.40 |
| 2021 | 582.50 | – | 644.05 | 510.85 |
Recent sessions
The 9 trading days to 27 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 27 Oct 2026 | 1,395.80 | 1,448.00 | 1,395.80 | 1,442.70 | 1,430.06 | 1,11,861 | 64.6% |
| 26 Oct 2026 | 1,389.40 | 1,409.70 | 1,369.00 | 1,395.80 | 1,390.90 | 1,16,091 | 61.5% |
| 23 Oct 2026 | 1,394.00 | 1,406.40 | 1,360.30 | 1,389.40 | 1,387.59 | 1,59,085 | 57.1% |
| 22 Oct 2026 | 1,335.20 | 1,398.00 | 1,335.00 | 1,390.80 | 1,383.14 | 1,08,077 | 38.9% |
| 21 Oct 2026 | 1,368.20 | 1,373.80 | 1,337.30 | 1,353.40 | 1,350.36 | 85,007 | 60.2% |
| 19 Oct 2026 | 1,370.00 | 1,378.00 | 1,354.70 | 1,368.20 | 1,367.83 | 1,84,487 | 62.3% |
| 16 Oct 2026 | 1,387.40 | 1,395.90 | 1,354.20 | 1,381.70 | 1,368.21 | 3,83,691 | 72.3% |
| 15 Oct 2026 | 1,411.00 | 1,415.90 | 1,372.10 | 1,387.40 | 1,385.80 | 1,33,378 | 44.9% |
| 14 Oct 2026 | 1,407.20 | 1,433.50 | 1,400.00 | 1,402.20 | 1,408.68 | 77,909 | 59.7% |
Company details
- NSE symbol
- VIJAYA
- BSE code
- 543350
- ISIN
- INE043W01024
- Industry
- Healthcare Services
- Website
- www.vijayadiagnostic.com
- CIN
- L85195TG2002PLC039075
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 2002
- Registered office
- 6-3-883/F, FPA Building, Near Topaz building, Punjagutta, Hyderabad 500082, Telangana
- Share registrar
- KFin Technologies Ltd
- Keeps the register of shareholders and handles transfers and dividend payments